Interestingly, the DNAJC16 gene is one of the chaperone families HSP40, which regulates AR and mediating sensitivity to chaperone inhibitors to aid in identifying new drug targets for efficacy in castration-resistant prostate cancer [113]. The gene discussed is DNAJC16; the disease is prostate carcinoma.